Movement disorders : official journal of the Movement Disorder Society
-
Case Reports Clinical Trial
High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial. Piracetam was demonstrated to be highly effective on tandem gait and gait ataxia in daily doses of 60 g. We suggest piracetam has a potential anti-ataxic effect in human cerebellar ataxia when used in considerably higher doses than those indicated for other purposes.